ZIM
ASTH icon

Zacks Investment Management’s Astrana Health ASTH Stock Holding History

Zacks Investment Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,270
Closed -$660K – 848
2025
Q3 		$660K Buy
+23,270
New +$631K 0.01% 450
2022
Q4 		– Sell
-102,466
Closed -$4M – 676
2022
Q3 		$4M Hold
102,466
– – 0.06% 193
2022
Q2 		$3.95M Sell
102,466
-599
-0.6% -$22.8K 0.06% 187
2022
Q1 		$5M Buy
103,065
+560
+0.5% +$28.9K 0.07% 187
2021
Q4 		$7.53M Sell
102,505
-10,485
-9% -$861K 0.11% 160
2021
Q3 		$10.3M Buy
112,990
+83,727
+286% +$7.12M 0.16% 133
2021
Q2 		$1.84M Sell
29,263
-6,171
-17% -$228K 0.03% 301
2021
Q1 		$960K Buy
+35,434
New +$852K 0.02% 370

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Zacks Investment Management's ASTH Position: Q4 2025 in Review

Zacks Investment Management sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 23,270 shares — an estimated $660K sold.

Zacks Investment Management first reported a position in ASTH in Q1 2021 and held it in 8 quarters. The position peaked at $10.3M in Q3 2021. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Zacks Investment Management reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Zacks Investment Management sold 23,270 Astrana Health shares in Q4 2025, an estimated $660K.
  • Zacks Investment Management first reported a position in Astrana Health in Q1 2021 and held it in 8 quarters.
  • Zacks Investment Management's Astrana Health position peaked at $10.3M in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Zacks Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.